In addition, the loss of ARID1A has been demonstrated in patient samples with atypical endometriotic lesions contiguous to clear-cell OC, raising the possibility that the loss of ARID1A may contribute to an early cancer-promoting event in endometriosis that leads to clear-cell OC [337]. This evidence concerns the gene ARID1A and cancer.